Hiv Stocks List

Recent Signals

Date Stock Signal Type
2021-05-17 AAZ NR7 Range Contraction
2021-05-17 BMY Crossed Above 20 DMA Bullish
2021-05-17 BMY Bollinger Band Squeeze Range Contraction
2021-05-17 BMY Cup with Handle Other
2021-05-17 BPM 20 DMA Support Bullish
2021-05-17 CNA 50 DMA Resistance Bearish
2021-05-17 CNA MACD Bearish Centerline Cross Bearish
2021-05-17 D4T4 Crossed Above 20 DMA Bullish
2021-05-17 D4T4 NR7 Range Contraction
2021-05-17 D4T4 Bollinger Band Squeeze Range Contraction
2021-05-17 FDBK Stochastic Buy Signal Bullish
2021-05-17 FDBK 200 DMA Resistance Bearish
2021-05-17 FDBK Spinning Top Other
2021-05-17 FDBK Bullish Engulfing Bullish
2021-05-17 FDBK Pocket Pivot Bullish Swing Setup
2021-05-17 GSK 200 DMA Resistance Bearish
2021-05-17 GSK Bollinger Band Squeeze Range Contraction
2021-05-17 GSK Stochastic Reached Overbought Strength
2021-05-17 KCT 50 DMA Support Bullish
2021-05-17 KCT Bollinger Band Squeeze Range Contraction
2021-05-17 KDR 20 DMA Resistance Bearish
2021-05-17 KDR 50 DMA Resistance Bearish
2021-05-17 LOK Cup with Handle Other
2021-05-17 TUNG 20 DMA Resistance Bearish
2021-05-17 UKR Narrow Range Bar Range Contraction
2021-05-17 UKR MACD Bullish Centerline Cross Bullish

Recent News for Hiv Stocks

Date Stock Title
May 18 GSK GSK recovers ground as it reports more positive COVID vaccine trial data
May 18 GSK China's Clover says its COVID-19 vaccine candidate shows immune response in mice
May 18 D4T4 When Should You Buy D4t4 Solutions Plc (LON:D4T4)?
May 17 GSK Sanofi Executives Say Covid Vaccine Could Be ‘Universal Booster’
May 17 GSK GSK/Sanofi Covid vaccine set for rollout after trial success
May 17 GSK Sanofi-GSK's COVID-19 Vaccine Candidate Reports Success In Mid-Stage Study
May 17 GSK GSK and Sanofi optimistic about COVID vaccine after phase 2 trials
May 17 GSK UPDATE 2-Sanofi/GSK report positive interim results for their COVID-19 shot
May 17 GSK Sanofi and Glaxo Are Back With a Covid-19 Vaccine
May 17 GSK GSK/vaccines: jab unit spin-off would be a long shot
May 17 GSK GSK moves to make up ground in vaccine race
May 14 GSK Activist investor Elliott warns GSK investors that ‘change is coming’
May 14 GSK People choosing to ditch their masks will be a ‘gradual process’: Doctor
May 14 CNA Hydrogen Gains a Toehold in Europe as a Cleaner Alternative to Gas and Coal
May 13 GSK CDC approves those fully vaccinated to largely ditch masks indoors
May 13 GSK CDC to Ease Indoor Mask Rule for Vaccinated People: Virus Update
May 13 GSK CureVac Reports Vaccine Data; Serb Cash Plan Works: Virus Update
May 13 GSK CureVac-GSK's Second-Gen COVID-19 Vaccine Candidate Shows Encouraging Action Against Variants In Animal Study
May 13 AAZ Here's Why I Think Anglo Asian Mining (LON:AAZ) Is An Interesting Stock
May 12 CNA The EMpower Top 100 Ethnic Minority Future Leaders 2021

The human immunodeficiency viruses (HIV) are two species of Lentivirus (a subgroup of retrovirus) that infect humans. Over time, they cause acquired immunodeficiency syndrome (AIDS), a condition in which progressive failure of the immune system allows life-threatening opportunistic infections and cancers to thrive. Without treatment, average survival time after infection with HIV is estimated to be 9 to 11 years, depending on the HIV subtype. In most cases, HIV is a sexually transmitted infection and occurs by contact with or transfer of blood, pre-ejaculate, semen, and vaginal fluids. Research has shown (for both same-sex and opposite-sex couples) that HIV is untransmittable through condomless sexual intercourse if the HIV-positive partner has a consistently undetectable viral load. Non-sexual transmission can occur from an infected mother to her infant during pregnancy, during childbirth by exposure to her blood or vaginal fluid, and through breast milk. Within these bodily fluids, HIV is present as both free virus particles and virus within infected immune cells.
HIV infects vital cells in the human immune system, such as helper T cells (specifically CD4+ T cells), macrophages, and dendritic cells. HIV infection leads to low levels of CD4+ T cells through a number of mechanisms, including pyroptosis of abortively infected T cells, apoptosis of uninfected bystander cells, direct viral killing of infected cells, and killing of infected CD4+ T cells by CD8+ cytotoxic lymphocytes that recognize infected cells. When CD4+ T cell numbers decline below a critical level, cell-mediated immunity is lost, and the body becomes progressively more susceptible to opportunistic infections, leading to the development of AIDS.

More about Hiv
Browse All Tags